Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone vs Paclitaxel after AC in Early Stage Breast Cancer
NCT00455533Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of ixabepilone in breast cancer, sponsored by Bristol Myers Squibb. Started Oct 2007; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00455533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455533.